Wissel J - Search Results

1

European consensus table on the use of botulinum toxin type A in adult spasticity.

Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P, Altavista MC, Cavazza S, Deltombe T, Duarte E, Geurts AC, Gracies JM, Haboubi NH, Juan FJ, Kasch H, Kätterer C, Kirazli Y, Manganotti P, Parman Y, Paternostro-Sluga T, Petropoulou K, Prempeh R, Rousseaux M, Slawek J, Tieranta N. Wissel J, et al. J Rehabil Med. 2009 Jan;41(1):13-25. doi: 10.2340/16501977-0303. J Rehabil Med. 2009. PMID: 19197564 Free article.

2

[Torticollis spasmodicus, blepharospasm and hemifacial spasm. Subjective evaluation of therapy by patients].

Birner P, Schnider P, Müller J, Wissel J, Fuchs I, Auff E. Birner P, et al. Among authors: wissel j. Nervenarzt. 1999 Oct;70(10):903-8. doi: 10.1007/s001150050594. Nervenarzt. 1999. PMID: 10554782 German.

3

[Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].

Wissel J, Müller J, Heinen F, Mall V, Sojer M, Ebersbach G, Poewe W. Wissel J, et al. Wien Klin Wochenschr. 1999 Oct 29;111(20):837-42. Wien Klin Wochenschr. 1999. PMID: 10586488 Clinical Trial. German.

4

A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.

Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C. Bakheit AM, et al. Among authors: wissel j. Stroke. 2000 Oct;31(10):2402-6. doi: 10.1161/01.str.31.10.2402. Stroke. 2000. PMID: 11022071 Clinical Trial.

5

Use of botulinum toxin type A in management of adult spasticity--a European consensus statement.

Ward AB, Aguilar M, De Beyl Z, Gedin S, Kanovsky P, Molteni F, Wissel J, Yakovleff A. Ward AB, et al. Among authors: wissel j. J Rehabil Med. 2003 Mar;35(2):98-9. doi: 10.1080/16501970306112. J Rehabil Med. 2003. PMID: 12691340 Free article. No abstract available.

6

European consensus statement on the use of botulinum toxin type A in the management of adult spasticity.

Ward AB, Wissel J, Molteni F, Yakovleff A, Gedin S, Aguilar M, Kanovsky P, Zegers de Beyl D. Ward AB, et al. Among authors: wissel j. Acta Neurol Belg. 2003 Mar;103(1):39. Acta Neurol Belg. 2003. PMID: 12704982 Review. No abstract available.

7

Ninhydrin sweat test: a simple method for detecting antibodies neutralizing botulinum toxin type A.

Voller B, Moraru E, Auff E, Benesch M, Poewe W, Wissel J, Müller J, Entner T, Bigalke H, Schnider P. Voller B, et al. Among authors: wissel j. Mov Disord. 2004 Aug;19(8):943-7. doi: 10.1002/mds.20073. Mov Disord. 2004. PMID: 15300661

8

[Botulinum toxin treatment -- state of the art 2000].

Auff E, Poewe W, Schnider P, Wissel J. Auff E, et al. Among authors: wissel j. Wien Klin Wochenschr. 2001;113 Suppl 4:1. Wien Klin Wochenschr. 2001. PMID: 15506043 German. No abstract available.

9

[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].

Wissel J, Entner T. Wissel J, et al. Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Wien Klin Wochenschr. 2001. PMID: 15506048 Review. German.

10

Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia--report of 19 cases.

Hecht MJ, Stolze H, Auf dem Brinke M, Giess R, Treig T, Winterholler M, Wissel J; German Spasticity Education Group. Hecht MJ, et al. Among authors: wissel j. Mov Disord. 2008 Jan 30;23(2):228-33. doi: 10.1002/mds.21809. Mov Disord. 2008. PMID: 17999430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page